secwatch.observer — SEC 8-K summary
======================================

Issuer:     CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL)
CIK:        0001100682
Form:       8-K
Filed at:   2022-01-11T23:59:59+00:00
Accession:  0001100682-22-000002
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Charles River Labs CFO David Smith to retire; provides preliminary 2022 guidance
--------------------------------------------------------------------------------

- CFO David R. Smith will retire; he will remain until a successor is named, expected by end of 2022.
- At J.P. Morgan Healthcare Conference, management presented preliminary 2022 outlook for revenue growth, organic revenue growth, non-GAAP operating margin, non-GAAP EPS, free cash flow, and capex.
- Specific numerical guidance was not included in the filing; slide deck is available on the company's IR website.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1100682/000110068222000002/0001100682-22-000002-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1100682/000110068222000002/crl-20220111.htm
  HTML page:      https://secwatch.observer/filing/0001100682-22-000002

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer